iLFT: A big assist in the recognition of liver disease in general practice

The burden of chronic liver disease worldwide is substantial, with approximately 2 million deaths annually attributed to cirrhosis or hepatocellular carcinoma caused by viral hepatitis, non-alcoholic fatty liver disease (NAFLD), or alcohol-related liver disease (ALD), in addition to other important but less common chronic liver diseases.1 Despite widespread availability of accurate assays to diagnose viral hepatitis and effective therapies for hepatitis B and C, millions of individuals remain undiagnosed or have limited access to care worldwide.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Editorial Source Type: research